Medlab Middle East 2024: A Perfect Finale, Striding Forward with Unyielding Momentum!
Thank you to all friends who participated in the Medlab Middle East 2024 exhibition! This event not only served as a stage to showcase the latest achievements of SEKBIO, but also stood as a vibrant gathering of innovation and cutting-edge medical technology.
Let's join together with Little Bo to revisit this unforgettable moment!
1. In-Depth Conversations with Professionals
We had the privilege of engaging in profound discussions with healthcare professionals from around the world. This not only deepened our understanding of the industry's needs but also provided invaluable feedback and insights for our team. Your perspectives fuel our progress!
2. Looking Towards the Future
Medlab Middle East 2024 was a platform to envision the future. SEKBIO remains committed to propelling the development of medical technology, relentlessly innovating to make even greater contributions to human health. We are confident and eagerly anticipate co-creating a brighter medical future with you!
Interested in more fascinating information about diagnostic reagents? Follow our public account!
Let's explore the forefront of healthcare together, shaping a healthier future!Thank you for your support, making our journey in healthcare even more diverse and colorful!
Related Immunoassays
- Cardiac Markers
-
Tumor Marker
-
PGII
-
G17
- CA50
-
CA125
- CA242
-
CA15-3
- CA19-9
- CA72-4
-
Pepsinogens I (PGI)
-
Human Epididymis 4 (HE4)
- Prostate-Specific Antigen (PSA)
- Squamous Cell Carcinoma (SCC)
- Neuron-Specific Enolase (NSE)
- Cytokeratin 19 Fragment (CYFRA21-1)
- Human Progastrin-releasing Peptide (ProGRP Tumor Marker)
- Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA II Tumor Marker)
- Alpha-fetoprotein(AFP)
-
CEA
-
Human Chitinase 3-like 1
-
PGII
- Inflammatory Marker
- Infectious Disease
- Hormones
- Thyroid Function
- Glucose Metabolism
- Bone Marker
- Others
-
Heterophilic Blocking Reagent
- Animal Diagnostics
